Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma

Journal of Neurosurgery

Volumn 94, Issue 3, 2001, Pages 464-473

  Nakada, M ^a   Kita, D ^a   Futami, K ^a   Yamashita, J ^a   Fujimoto, N ^a   Sato, H ^a   Okada, Y ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dissemination; Glioma; Invasion; Membrane type matrix metalloproteinase; Tissue inhibitor of metalloproteinase

Indexed keywords

GELATINASE A; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; ENZYME ANALYSIS; ENZYME IMMUNOASSAY; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROPHOTOGRAPHY; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 0034859529     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2001.94.3.0464     Document Type: Article

References (42)

1. Membrane-type 1 matrix metalloprotease (MTI-MMP) enables invasive migration of glioma cells in central nervous system white matter
2. Cultured human glial and glioma cells
3. Matrix metalloproteinase-2 activation modulates glioma cell migration
4. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2
5. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas
6. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies
7. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies
8. Glioma invasion in the central nervous system
9. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
10. Regulation of matrix metallopmteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying upregulation of membrane type-1 MMP
11. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
12. Expression of matrix metalloproteinases and their inhibitors in human brain tumors
13. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads
14. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase
15. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma
16. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors
17. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells
18. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells
19. Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro
20. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors
21. Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors
22. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors
23. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant glioma cell lines: Implications for the growth and cellular invasion of the extracellular matrix
24. Brevican is degraded by matrix metalloproteinases (MMPs) and aggrecanase-1 (ADAMTS4) at the different sites
25. Enhanced production and activation of progelatinase A mediated by membranetype 1 matrix metalloproteinase in human papillary thyroid carcinomas
26. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas
27. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas
28. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas
29. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
30. Proteinases and matrix degradation
31. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties
32. The extracellular matrix of the central and peripheral nervous systems: Structure and function
33. v-Src activates the expression of 92kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines
34. A matrix metalloproteinase expressed on the surface of invasive tumour cells
35. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo
36. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase
37. Enhanced production of progelatinase A and its activation mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implications for lymph node metastasis
38. Tumor cell interactions with the extracellular matrix during invasion and metastasis
39. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas
40. Glioma invasion in vitro: Regulation by matrix metalloprotease-2 and protein kinase C
41. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro